CRL vs NCSM · rev $2.00B vs P/E 6.6, rev $84.0M
Charles River Laboratories (CRL) versus NCS Multistage Holdings Inc (NCSM) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
NCS Multistage Holdings Inc (NCSM) is a oil & gas equipment & services company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported NCSM revenue for 2026-06-30 was $84.0M. Net income was -$5.0M. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. NCSM currently screens at market cap $122.1M and trailing P/E 6.6.
CRL currently screens at market cap $7.78B. NCSM currently screens at market cap $122.1M and trailing P/E 6.6.
Not investment advice. Open the CRL and NCSM stock pages for the full models.
Not investment advice.